» Articles » PMID: 19168855

Protein Kinase C in Heart Failure: a Therapeutic Target?

Overview
Journal Cardiovasc Res
Date 2009 Jan 27
PMID 19168855
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Heart failure (HF) afflicts about 5 million people and causes 300,000 deaths a year in the United States alone. An integral part of the pathogenesis of HF is cardiac remodelling, and the signalling events that regulate it are a subject of intense research. Cardiac remodelling is the sum of responses of the heart to causes of HF, such as ischaemia, myocardial infarction, volume and pressure overload, infection, inflammation, and mechanical injury. These responses, including cardiomyocyte hypertrophy, myocardial fibrosis, and inflammation, involve numerous cellular and structural changes and ultimately result in a progressive decline in cardiac performance. Pharmacological and genetic manipulation of cultured heart cells and animal models of HF and the analysis of cardiac samples from patients with HF are all used to identify the molecular and cellular mechanisms leading to the disease. Protein kinase C (PKC) isozymes, a family of serine-threonine protein kinase enzymes, were found to regulate a number of cardiac responses, including those associated with HF. In this review, we describe the PKC isozymes that play critical roles in specific aspects of cardiac remodelling and dysfunction in HF.

Citing Articles

Transcriptomics reveal stretched human pluripotent stem cell-derived cardiomyocytes as an advantageous hypertrophy model.

Pohjolainen L, Ruskoaho H, Talman V J Mol Cell Cardiol Plus. 2025; 2():100020.

PMID: 39802492 PMC: 11708431. DOI: 10.1016/j.jmccpl.2022.100020.


An Update on Protein Kinases as Therapeutic Targets-Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases.

Silnitsky S, Rubin S, Zerihun M, Qvit N Int J Mol Sci. 2023; 24(24).

PMID: 38139428 PMC: 10743896. DOI: 10.3390/ijms242417600.


Apelin receptor inhibition in ischemia-reperfused mouse hearts protected by endogenous n-3 polyunsaturated fatty acids.

Zheng S, Tan W, Li X, Wang L, Zhu C, Pyle W Front Pharmacol. 2023; 14:1145413.

PMID: 37942483 PMC: 10628527. DOI: 10.3389/fphar.2023.1145413.


12--tetradecanoylphorbol-13-acetate Reduces Activation of Hepatic Stellate Cells by Inhibiting the Hippo Pathway Transcriptional Coactivator YAP.

Kim C, Yoon Y, Kim M, Baik S, Ryu H, Park I Cells. 2023; 12(1).

PMID: 36611885 PMC: 9818550. DOI: 10.3390/cells12010091.


The Role of PKC-MAPK Signalling Pathways in the Development of Hyperglycemia-Induced Cardiovascular Complications.

Jubaidi F, Zainalabidin S, Taib I, Abdul Hamid Z, Anuar N, Jalil J Int J Mol Sci. 2022; 23(15).

PMID: 35955714 PMC: 9369123. DOI: 10.3390/ijms23158582.


References
1.
Wang J, Paradis P, Aries A, Komati H, Lefebvre C, Wang H . Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4. Mol Cell Biol. 2005; 25(22):9829-44. PMC: 1280254. DOI: 10.1128/MCB.25.22.9829-9844.2005. View

2.
Disatnik M, Buraggi G, Mochly-Rosen D . Localization of protein kinase C isozymes in cardiac myocytes. Exp Cell Res. 1994; 210(2):287-97. DOI: 10.1006/excr.1994.1041. View

3.
Mochly-Rosen D, Wu G, Hahn H, Osinska H, Liron T, Lorenz J . Cardiotrophic effects of protein kinase C epsilon: analysis by in vivo modulation of PKCepsilon translocation. Circ Res. 2000; 86(11):1173-9. DOI: 10.1161/01.res.86.11.1173. View

4.
Grossman S, Alavi J, Supko J, Carson K, Priet R, Dorr F . Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-alpha delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas. Neuro Oncol. 2005; 7(1):32-40. PMC: 1871621. DOI: 10.1215/S1152851703000353. View

5.
Inagaki K, Koyanagi T, Berry N, Sun L, Mochly-Rosen D . Pharmacological inhibition of epsilon-protein kinase C attenuates cardiac fibrosis and dysfunction in hypertension-induced heart failure. Hypertension. 2008; 51(6):1565-9. PMC: 3646632. DOI: 10.1161/HYPERTENSIONAHA.107.109637. View